419 related articles for article (PubMed ID: 26851175)
1. Research progress on berberine with a special focus on its oral bioavailability.
Liu CS; Zheng YR; Zhang YF; Long XY
Fitoterapia; 2016 Mar; 109():274-82. PubMed ID: 26851175
[TBL] [Abstract][Full Text] [Related]
2. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine.
Xiong W; Sang W; Linghu KG; Zhong ZF; Cheang WS; Li J; Hu YJ; Yu H; Wang YT
Int J Nanomedicine; 2018; 13():3781-3793. PubMed ID: 29988733
[TBL] [Abstract][Full Text] [Related]
3. [Berberine action targets and its absorption behavior：how to use old drug for new mechanisms].
Yuan ZY; Wang YG; Chai YS; Hu J; Jiang JF; Yan XJ; Du LJ
Zhongguo Zhong Yao Za Zhi; 2016 Jun; 41(12):2362-2370. PubMed ID: 28901086
[TBL] [Abstract][Full Text] [Related]
4. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux.
Shan YQ; Ren G; Wang YX; Pang J; Zhao ZY; Yao J; You XF; Si SY; Song DQ; Kong WJ; Jiang JD
Metabolism; 2013 Mar; 62(3):446-56. PubMed ID: 23079743
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Berberine Bioavailability between Oral and Rectal Administrations in Rats.
Mori N; Oda K; Takakura H; Tanaka Y; Yokooji T; Murakami T
Biol Pharm Bull; 2023; 46(11):1639-1642. PubMed ID: 37914368
[TBL] [Abstract][Full Text] [Related]
6. MgAl monolayer hydrotalcite increases the hypoglycemic effect of berberine by enhancing its oral bioavailability.
Wang A; Yang W; Yang X; Mei X; Hu T; Liang R; Meng D; Yan D
Biomed Pharmacother; 2020 Jul; 127():110140. PubMed ID: 32380387
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine.
Buchanan B; Meng Q; Poulin MM; Zuccolo J; Azike CG; Gabriele J; Baranowski DC
PLoS One; 2018; 13(3):e0194979. PubMed ID: 29579096
[TBL] [Abstract][Full Text] [Related]
8. Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: part 2. development of oral dosage formulations.
Murakami T; Bodor E; Bodor N
Expert Opin Drug Metab Toxicol; 2023 Mar; 19(3):139-148. PubMed ID: 37060323
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats.
Chen W; Miao YQ; Fan DJ; Yang SS; Lin X; Meng LK; Tang X
AAPS PharmSciTech; 2011 Jun; 12(2):705-11. PubMed ID: 21637946
[TBL] [Abstract][Full Text] [Related]
10. Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Physicochemical and pharmacokinetic properties.
Murakami T; Bodor E; Bodor N
Expert Opin Drug Metab Toxicol; 2023 Mar; 19(3):129-137. PubMed ID: 37057922
[TBL] [Abstract][Full Text] [Related]
11. Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid.
Godugu C; Patel AR; Doddapaneni R; Somagoni J; Singh M
PLoS One; 2014; 9(3):e89919. PubMed ID: 24614362
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.
Wang Y; Tong Q; Shou JW; Zhao ZX; Li XY; Zhang XF; Ma SR; He CY; Lin Y; Wen BY; Guo F; Fu J; Jiang JD
Theranostics; 2017; 7(9):2443-2451. PubMed ID: 28744326
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine.
Li YH; Li Y; Yang P; Kong WJ; You XF; Ren G; Deng HB; Wang YM; Wang YX; Jiang JD; Song DQ
Bioorg Med Chem; 2010 Sep; 18(17):6422-8. PubMed ID: 20673726
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interactions between metformin and berberine in rats: Role of oral administration sequences and microbiota.
Lyu Y; Zhang Y; Yang M; Lin L; Yang X; Cheung SCK; Shaw PC; Chan PKS; Kong APS; Zuo Z
Life Sci; 2019 Oct; 235():116818. PubMed ID: 31473193
[TBL] [Abstract][Full Text] [Related]
15. Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats.
Chen W; Fan D; Meng L; Miao Y; Yang S; Weng Y; He H; Tang X
Drug Dev Ind Pharm; 2012 Jan; 38(1):104-10. PubMed ID: 21774632
[TBL] [Abstract][Full Text] [Related]
16. An Updated Review on Therapeutic Potential and Recent Advances in Drug Delivery of Berberine: Current Status and Future Prospect.
Mujtaba MA; Akhter MH; Alam MS; Ali MD; Hussain A
Curr Pharm Biotechnol; 2022; 23(1):60-71. PubMed ID: 33557735
[TBL] [Abstract][Full Text] [Related]
17. Research progress on pharmacological effects and bioavailability of berberine.
Cui Y; Zhou Q; Jin M; Jiang S; Shang P; Dong X; Li L
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; ():. PubMed ID: 38888754
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study of pharmacokinetics and tissue distribution of 8-cetylberberine and berberine in rats].
Hu YL; Chen C; Zou ZY; Li XG; Ye XL
Yao Xue Xue Bao; 2014 Nov; 49(11):1582-7. PubMed ID: 25757286
[TBL] [Abstract][Full Text] [Related]
19. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
[TBL] [Abstract][Full Text] [Related]
20. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles.
Xue M; Yang MX; Zhang W; Li XM; Gao DH; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
Int J Nanomedicine; 2013; 8():4677-87. PubMed ID: 24353417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
